Answers are grounded in this paper and cite their sources.
Introduction Risk reclassification tables are becoming an increasingly popular approach for evaluating the incremental prognostic information provided by a new risk marker beyond an established set of risk markers [1-9]. These cross-tabulations of estimated absolute risk display the allocation of study subjects across clinically relevant risk strata both before and after
No takes yet. Share an insight, caveat, or question.
Brent A. Williams (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: